Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma

Fig. 5

Correlation analysis of ZBTB9 level and immunity. Relations with tumor-infiltrating lymphocytes in cancers (A), and top 4 results in LIHC (B). Relations with immune inhibitors in cancers (C), and top 4 correlation results (D). Relations with stimulators in cancers (E). Relations with immune and top 4 results in LIHC (F) (*p < 0.05; **p < 0.01; ***p < 0.001)

Back to article page